Focusing on emerging technologies, products and services improving women’s health and wellness throughout their lives.
Companies to be announced Soon
NEXT PITCH CALL WILL BE ON SEP 11, 2019
Past Pitch Videos
Materna & Sana Health Pitch Review
Companies in Diligence
MitraGen is a cardiovascular device company developing a unique and compelling approach to Transcatheter Mitral Valve Repair (TMVR).
UDoTest is a software delivery platform designed to simplify and personalize consumer at-home testing for enterprises.
Sana Health is redefining the way pain is being treated with a non-invasive device helping patients manage chronic pain.
Madorra has developed the first effective, non- hormonal treatment and new treatment paradigm for vaginal dryness.
Future Family helps families more easily afford fertility services like IVF and egg freezing.
Prime Genomics is creating innovative new ways to transform the cancer screening market by using saliva testing.
|Company Name||CEO||Location||Amount Invested||Pre-Money Valuation||Date Invested||Round||Most Recent Valuation|
|Prime Genomics||Robert Feldman||Mountain View, CA||$500K||$3.8M||July 2019||Equity||No Change|
|Madorra||Holly Rockweiler||Portland, OR||$400K||$5.4M||July 2019||Equity||No Change|
|Future Family||Claire Tompkins||San Francisco, CA||$200K||$23M||JSeptember 2018||Equity||No Change|